Posted on April 30, 2008 by Dani Dechter
Evogene and Compugen have both made headlines today. The two companies are related - Evogen was spun off of Compugen six years ago as an independent startup. Evogen will receive NIS 7.2 million from venture capital fund AquAgro. The ag-biotech startup develops improved plants for the agricultural and biofuel industries through [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: aquagro, compugen, evogene | No Comments »
Posted on April 29, 2008 by Dani Dechter
According to webware, tech-support startup Fixya will announce a partnership with Best Buy whereby “customers wanting to perform their own fixes (or trying to dig others out of trouble) can go to the Best Buy Web site and access http://geeksquad.fixya.com from the “Customer Service” tab. They can search by product, SKU, manufacturer, or product category, [...]
Filed under: Biotech, Communications, Healthcare, Medical Devices, Medicine, Other, Software, Web 2.0 | Tagged: cleveland clinic foundation, erez gavish, fixya, intercure, mazor, perytons, resperate | No Comments »
Posted on April 27, 2008 by Dani Dechter
Today Israel’s innovators made all kinds of headlines from cleantech to medical devices to software security.
Let’s start with TechnoSpin. The four year old startup has raised $8 million from US VC 21 Ventures. They develop and produce rotors for small wind turbines which, it claims, are cheaper to produce and more easily assembled than competitor’s [...]
Filed under: Alternative Energy, Biotech, Cleantech, Healthcare, Hi-Tech, Media Technologies, Medical Devices, Security, Semiconductors, Software, Uncategorized | Tagged: 21 ventures, applicure, biomedix, endogun, gizmox, maayan, meytag, technospin, trafalgar | No Comments »
Posted on April 25, 2008 by Dani Dechter
Boston Scientific will sell its stakes in startup companies, including those in Israeli startups such as superDimension, MEL Medical Enterprises, MediGuide, E-Pill Pharma, Beta O2 Technologies, Brainsgate and VisionCare Ophthalmic Technologies, according to Globes, in order to focus on its core business.
The medical device giant has invested nearly $6 billion in new technologies over the [...]
Filed under: Biotech, Medical Devices | Tagged: beta o2, boston scientific, brainsgate, e-pill, mediguide, mel medical, superdimension, visioncare | 2 Comments »
Posted on April 16, 2008 by Dani Dechter
Evogene is an Israeli startup founded in 2002 that aims to generate improved crops and new agricultural biotechnology products in an economically efficient way. Initially a division of Compugen, Evogene has just signed a partnership with Rehovot-based CBD Technologies, a wholly owned subsidiary of FuturaGene, to collaborate on the improvement of cotton fiber properties.
Under the agreement, CBD [...]
Filed under: Biotech | Tagged: athlete, cbd, compugen, cotton, evogene, futuragene | No Comments »
Posted on April 9, 2008 by Dani Dechter
Protalix BioTherapeutics announced yesterday that it received $4 million from Israel’s Office of the Chief Scientist to help it advance its clinical and pre-clinical drug development programs. The government grant program was setup to aid tech companies that have trouble seeking R&D financing from private investors.
Protalix, which was founded in 1994, intends to use [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: protalix, david aviezer, office of the chief scientist, gaucher, fabry, prgcd | No Comments »
Posted on March 30, 2008 by Dani Dechter
ES Vascular has developed highly-advanced surgical staplers for endovascular surgery, open aortic surgery and critical limb ischemia (CLI). Private investors have now invested $3 million in hopes that the company’s Open Aortic Stapler will soon receive the CE mark which will allow it to begin marketing in Europe. The money should also [...]
Filed under: Biotech, Healthcare, Medical Devices | Tagged: critical limb, edward shifrin, es vascular, open aortic, stapler, vascular surgery | 2 Comments »
Posted on March 29, 2008 by Dani Dechter
Israeli biotech company Core Dynamics has released the results of a study this month that demonstrate the feasibility of recovering a functional heart after it has been frozen and then thawed. Its unique controlled freezing method, which is based on the Company’s patented Multi Thermal Gradient (MTG) freezing technology, reduces the damage to cells [...]
Filed under: Biotech, Healthcare | Tagged: core dynamics, cryopreservation, donors, freezing technology, hadassah medical, muti thermal gradient, organ transplants, organs | 3 Comments »
Posted on March 27, 2008 by Dani Dechter
Modigene Inc. is a biopharmaceutical company founded in Israel in 2001 that has developed technology that creates longer-lasting, proprietary versions of already approved therapeutic proteins. One of these therapeutic proteins is FHS, a naturally occurring female hormone that can be added as a supplement to women with fertility problems to increase their chances of [...]
Filed under: Biotech, Healthcare, Medical Devices | Tagged: cpt, fhs, frost group, modigene, organon, philip frost, therapeutic proteins | No Comments »
Posted on March 25, 2008 by Dani Dechter
BioLineRx, an Israeli drug development company, has announced that the first heart attack patient has emerged unscathed from a Phase 1/2 clinical trial study of its BL-1040, a breakthrough approach to supporting damaged cardiac tissue. The trial is using up to 30 patients in several sites in Germany, Belgium and Israel and is designed [...]
Filed under: Biotech, Healthcare, Medical Devices | Tagged: biolinerx, bl-1040, cardiac tissue, giza ventures, hadasit, heart attack, jonathan leor, liquid polymer, morris c. laster, pitango capital, teva | 1 Comment »